| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 430.50M | 396.70M | 178.00M | 133.20M | 122.20M | 113.40M |
| Gross Profit | 424.50M | 391.80M | 176.30M | 131.20M | 119.90M | 111.50M |
| EBITDA | 386.75M | 468.30M | 161.70M | 116.20M | 110.20M | 16.00M |
| Net Income | 314.40M | 347.90M | 118.70M | 734.50M | 257.30M | -5.70M |
Balance Sheet | ||||||
| Total Assets | 7.97B | 6.61B | 6.48B | 3.66B | 2.63B | 2.42B |
| Cash, Cash Equivalents and Short-Term Investments | 147.30M | 41.80M | 111.90M | 51.30M | 51.40M | 81.80M |
| Total Debt | 2.84B | 2.10B | 2.12B | 1.03B | 842.70M | 932.60M |
| Total Liabilities | 3.25B | 2.48B | 2.51B | 1.09B | 888.70M | 979.90M |
| Stockholders Equity | 4.69B | 4.09B | 3.94B | 2.56B | 1.73B | 1.43B |
Cash Flow | ||||||
| Free Cash Flow | 297.50M | 284.00M | 117.30M | 54.20M | 60.50M | 42.30M |
| Operating Cash Flow | 300.00M | 316.90M | 123.10M | 105.20M | 86.10M | 60.40M |
| Investing Cash Flow | -56.10M | -7.90M | 195.70M | -377.10M | -53.00M | -214.90M |
| Financing Cash Flow | -123.20M | -339.70M | -249.90M | 271.80M | -63.50M | 215.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £4.36B | 7.70 | 7.16% | 6.67% | 43.70% | 40.28% | |
75 Outperform | £3.65B | 3.98 | 7.75% | 5.85% | -20.83% | ― | |
73 Outperform | £4.21B | 11.16 | 3.85% | 6.34% | 10.69% | 135.58% | |
71 Outperform | £157.72M | 9.16 | 7.33% | 7.43% | -10.95% | -30.09% | |
67 Neutral | £234.04M | 5.97 | 9.81% | 6.64% | ― | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | £397.33M | 6.81 | 7.51% | 5.15% | -3.98% | 412.08% |